Acceleron Pharma

Acceleron Pharma (XLRN), a clinical stage biopharmaceutical company, focuses on the discovery, development and commercialization of protein therapeutics for cancer and rare diseases. This stock closed up 4.3% to $30 in Fridays trading session.

Friday's Volume 1.20 million
Three-Month Average Volume: 143,630
Volume % Change: 1236%

>>5 Stocks Under $10 Set to Soar

From a technical perspective, XLRN spiked sharply higher here right above some near-term support at $26.15 with monster upside volume. This move is quickly pushing shares of XLRN within range of triggering a major breakout trade. That trade will hit if XLRN manages to take out some key near-term overhead resistance levels at $30.62 to its all-time high at $31.43 with high volume.

Traders should now look for long-biased trades in XLRN as long as it's trending above Friday's low of $27.12 or above more near-term support at $26.15 and then once it sustains a move or close above those breakout levels with volume that hits near or above 143,630 shares. If that breakout hits soon, then XLRN will set up to enter new all-time-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $35 to $40.

If you liked this article you might like

Biotech 2013 by the Numbers: A Blockbuster Year

3 Health Care Stocks Spiking on Big Volume

Trade-Ideas: Gentium SpA (GENT) Is Today's New Lifetime High Stock

4 Stocks Triggering Breakout Trades